Role of the microvascular endothelium in progressive renal disease

Duk-Hee Kang, John Kanellis, Christian Hugo, Luan D Truong, Sharon Anderson, Dontscho Kerjaschki, George F Schreiner, Richard J. Johnson

Research output: Contribution to journalReview ArticleResearchpeer-review

408 Citations (Scopus)

Abstract

The role of the vascular endothelium in progressive renal disease is not well understood. This review presents evidence that progressive renal disease is characterized by a progressive loss of the microvasculature. The loss of the microvasculature correlates directly with the development of glomerular and tubulointerstitial scarring. The mechanism is mediated in part by a reduction in the endothelial proliferative response, and this impairment in capillary repair is mediated by alteration in the local expression of both angiogenic (vascular endothelial growth factor) and antiangiogenic (thrombospondin 1) factors in the kidney. The alteration in balance of angiogenic growth factors is mediated by both macrophage-associated cytokines (interleukin-1β) and vasoactive mediators. Finally, there is intriguing evidence that stimulation of angiogenesis and/or capillary repair may stabilize renal function and slow progression and that this benefit occurs independently of effects on BP or proteinuria. Therefore, angiogenic agents may represent a novel therapeutic approach for slowing the progression of renal disease.

Original languageEnglish
Pages (from-to)806-816
Number of pages11
JournalJournal of the American Society of Nephrology
Volume13
Issue number3
Publication statusPublished - 2002
Externally publishedYes

Cite this